Home
News
Editorial
MD(e)B(unker)
Related Researches
Di Bella's Foundation
1960-1969
1970-1979
1980-1989
1990-1999
2000-2009
2010-2019
2020-2029
Science news
Scientific Documentation
About us...
Biography
Bibliography
The Method
Di Bella's Method!
1998 Trial!
Media
Video Publications
News-Papers
Press
Testimonial
Testimonies
Video Gallery
Congresses
Video Testimonies
TV & C.
Case History
Lung
Lymphomas
Non-Hodgkin Lymphomas
Hodgkin Lymphomas
Mediastinum
Mesothelioma
Myeloma
Pancreas
Scientific Publications
F.A.Q.
Useful Links
User Side
Vademecum
CouponChief - Resources for Cancer Patients
Contact Us
Home page
News
Related Researches
2000-2009
Title
Created Date
Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3
29 August 2014
Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism
26 August 2014
Randomized controlled clinical trial of a combination of somatostatin analog and dexamethasone plus zoledronate vs. zoledronate in patients with androgen ablation-refractory prostate cancer
25 August 2014
Combination of somatostatin analog, dexamethasone, and standard androgen ablation therapy in stage D3 prostate cancer patients with bone metastases
20 August 2014
Long-term response to combination therapy with estramustine and somatostatin analogue in a patient with androgen ablation-refractory prostate cancer
20 August 2014
Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans
20 August 2014
Melatonin as a major skin protectant: from free radical scavenging to DNA damage repair
18 August 2014
Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression
18 August 2014
Melatonin in pathogenesis and therapy of cancer
15 August 2014
Retinoid, retinoic acid receptor beta and breast cancer
15 August 2014
Display #
5
10
15
20
25
30
50
100
All
Page 85 of 110
Start
Prev
80
81
82
83
84
85
86
87
88
89
Next
End
Search
Follow us...
Latest
Tumor-associated macrophages facilitate oral squamous cell carcinomas migration and invasion by MIF/NLRP3/IL-1β circuit: A crosstalk interrupted by melatonin
Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors
Impaired vitamin D signaling reveals neutrophils as key drivers of prostate cancer dissemination
Melatonin attenuates bone cancer pain via the SIRT1/HMGB1 pathway
Pretreatment with melatonin protects against cyclophosphamide-induced oxidative stress and renal damage in mice
Melatonin Pharmacological Blood Levels Increase Total Antioxidant Capacity in Critically Ill Patients
A Review of Biological and Pharmacological Actions of Melatonin: Oxidant and Prooxidant Properties
Melatonin as Antioxidant Under Pathological Processes
Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage
Melatonin as antioxidant, geroprotector and anticarcinogen
The potential therapeutic effects of melatonin on breast cancer: An invasion and metastasis inhibitor
Does the use of melatonin overcome drug resistance in cancer chemotherapy?
Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved
Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
Multifaceted Role of Vitamin D in Breast Cancer: A Systematic Review of Genetic and Pathway-Based Mechanisms
Multifaceted roles of melatonin in oncology: an insight into its therapeutic potential in cancer management
Nocturnal Melatonin Deficiency in Colorectal Cancer: Independent Predictive Value Beyond Sleep Quality
Most Read
The Di Bella Method (DBM)
About melatonin - 1996
All-trans-retinoic acid and cancer
Biography
The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
Somatostatin in oncology, the overlooked evidences
Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
How effective is chemo therapy?
Bibliography
Complete objective response to biological therapy of plurifocal breast carcinoma
Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
Vademecum
Frequently Asked Questions
Declaration recommends eliminate the use of Impact factor for research evaluation
Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer